Search results
Results from the WOW.Com Content Network
Serotonin reuptake inhibitors should not be abruptly discontinued after extended therapy, and whenever possible, should be tapered over several weeks to minimize discontinuation-related symptoms which may include nausea, headache, dizziness, chills, body aches, paresthesias, insomnia, and brain zaps. Paroxetine may produce discontinuation ...
More severe symptoms include fever, seizures, irregular heartbeat, delirium, and coma. [75] [76] [11] If signs or symptoms arise, discontinue treatment with serotonergic agents immediately. [75] It is recommended to washout 4 to 5 half-lives of the serotonergic agent before using an MAO inhibitor. [77]
Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris, France. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers ...
If your doctor thinks you may have early signs of cognitive health issues, Medicare covers a separate visit for a more thorough review to check for conditions such as dementia, depression, anxiety ...
SNRIs work by affecting specific neurotransmitters in the brain, which are chemical messages sent between brain cells responsible for functions like circadian rhythm, mood, memory, energy ...
In general, symptoms and signs that suggest a rise in ICP include headache, vomiting without nausea, ocular palsies, altered level of consciousness, back pain and papilledema. If papilledema is protracted, it may lead to visual disturbances, optic atrophy, and eventually blindness. The headache is classically a morning headache that may wake ...
Thankfully, there are brain supplements for adults – specifically, vital vitamins that have been shown to boost brain function. These vitamins include B vitamins, vitamin D and omega-3 fatty acids.
Sulpiride, sold under the brand name Dogmatil among others, is an atypical antipsychotic (although some texts have referred to it as a typical antipsychotic) [10] medication of the benzamide class which is used mainly in the treatment of psychosis associated with schizophrenia and major depressive disorder, and is sometimes used in low dosage to treat anxiety and mild depression.